Cewkowo-środmiąższowe zapalenie nerek u chorej przewlekle zażywającej furosemid

• Authors: Anna Bekier-Żelawska , Jan Duława

Title variants

EN

Tubulointerstitial nephritis revealed in patient on long-term furosemide therapy

• Languages of publication: PL

Abstracts

EN

This case study presents the problem of developing tubulointerstitial nephritis and nephrocalcinosis in a patient on long-term loop diuretic therapy ( furosemide). Complications of prolonged furosemide abuse lead to calcium metabolism disorders and may also cause nephrolithiasis and nephrocalcinosis. First line treatment, in particular cases, seems to be cessation of furosemide intake.

PL

W przedstawionej pracy omówiono przypadek cewkowo-śródmiąższowego zapalenia oraz wapnicy nerek u chorej długotrwale zażywającej diuretyk pętlowy (furosemid). Powikłania przewlekłej terapii furosemidem, prowadzące do zaburzeń gospodarki wapniowej, skutkują m.in. powstawaniem kamicy i wapnicy nerek . Leczeniem z wyboru, w uzasadnionych przypadkach, jest całkowite odstawienie leku moczopędnego.

Keywords

EN

cewkowo-śródmiąższowe zapalenie nerek; furosemid; furosemide; nephrocalcinosis; tubulointerstitial nephritis; wapnica nerek

Discipline

• MEDICINE: MEDICINE

• Journal: Annales Academiae Medicae Silesiensis
• Year: 2009
• Volume: 63
• Issue: 6
• Pages: 81-85

Contributors

author

Anna Bekier-Żelawska

• Klinika Chorób Wewnętrznych i Metabolicznych SUM, 40-635 Katowice, ul. Ziołowa 45/47; tel. [phone] fax. [phone],

author

Jan Duława

• Klinika Chorób Wewnętrznych i Metabolicznych SUM w Katowicach

References

• 1. Albright F, Baird PC, Cope O, Bloomberg E. Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci. 1934;187(1):49-65.
• 2. Tykarski A. Manitius J. Diuretyki w leczeniu nadciśnienia tętniczego i chorób nerek Gdańsk 2006. Wydanie I.
• 3. Hufnagle KG, Khan SN, Penn D, et al. Renal calcifi cations: A complication of long-term furosemide therapy in pre-term infants. Pediatrics 1982 Sep; 70(3):360-3.
• 4. Kim YG, Kim B, Kim MK, Chung SJ, Han HJ, Ryu JA, Lee YH i wsp. Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant. 2001 Dec;16(12):2303-9.
• 5. Jennings M, Shortland JR, Maddocks JL. Interstitial nephritis associated with frusemide. J R Soc Med. 1986 Apr;79(4):239- 40.
• 6. Park CW, You HY, Kim YK, Chang YS, Shin YS, Hong CK, Kim YC, Bang BK. Chronic tubulointerstitial nephritis and distal renal tubular acidosis in a patient with frusemide abuse. Nephrol Dial Transplant. 2001 Apr;16(4):867-9.
• 7. Pattaragarn A, Fox J, Alon US. Eff ect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. Kidney International (2004) 65, 1684–1689
• 8. Pressler CA, Heinzinger J, Jeck N, Waldegger P, Pechmann U, Reinalter S, Konrad M i wsp. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter. J Am Soc Nephrol. 2006 Aug;17(8):2136-42.
• 9. Balogun RA, Adams ND, Palmisano J, et al. Focal segmental glomerulosclerosis, proteinuria and nephrocalcinosis associated with renal tubular acidosis. Nephrol Dial Transplant. Feb 2002;17(2):308-10.
• 10. Saarela T, Lanning P, Koivisto M, Paavilainen T. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr. 1999 Aug;158(8):668-72.
• 11. Solivetti FM, Paganelli C, Zoff oli M, Bacaro D, Quintigliano D, Nasrollah N. Nephrocalcinosis induced by long-term therapy with furosemide. J Clin Ultrasound. 1997 Nov-Dec;25(9):519-20.
• 12. Alon US. Nephrocalcinosis. Curr Opin Pediatr. 1997 Apr;9(2):160-5. Review.
• 13. Kugelman A, Durand M, Garg M. Pulmonary eff ect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. Pediatrics. 1997 Jan;99(1):71-5.
• 14. Pope JC 4th, Trusler LA, Klein AM, Walsh WF, Yared A, Brock JW. The natural history of nephrocalcinosis in premature infants treated with loop diuretics. 3rd.J Urol. 1996 Aug;156(2 Pt 2):709-12.
• 15. Alon US, Kaplan RA, Gratny LL, Nichols MA. Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat. Pediatr Nephrol. 1996 Apr;10(2):191-4.
• 16. Alon US, Scagliotti D, Garola RE. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr. 1994 Jul;125(1):149- 51.
• 17. Kenney IJ, Aiken CG, Lenney W. Frusemide- induced nephrocalcinosis in very low birth weight infants. Pediatr Radiol. 1988;18(4):323-5.
• 18. Myracle MR, McGahan JP, Goetzman BW, Adelman RD. Ultrasound diagnosis of renal calcifi cation in infants on chronic furosemide therapy. J Clin Ultrasound. 1986 May;14(4):281-7.
• 19. Tajiri J, Nakayama M, Sato T, Isozaki S, Uchino K. Pseudo-Bartter’s syndrome due to furosemide abuse: report of a case and an analytical review of Japanese literature. Jpn J Med. 1981 Jul;20(3):216-21.
• 20. Lin MT, Tsau YK, Tsai WY, Tsai WS, Lu FL, Hsiao PH, Chen CH. Nephrocalcinosis in childhood. Acta Paediatr Taiwan. 1999 Jan-Feb;40(1):27-30.
• 21. Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A I wsp. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 2000 Aug;11(8):1449-59
• 22. Karolina Kędzierska, Kazimierz Ciechanowski, Maria Pietrzak-Nowacka. Pseudo- Gitelman’s syndrome as a consequence of loop diuretics abuse. Polskie Archiwum Medycyny Wewnętrznej 2001, 105(6), s.501-504
• 23. Kurschat C, Heering P, Grabensee B. Gitelman’s syndrome: an important diff erential diagnosis of hypokalemia Dtsch Med Wochenschr. 2003 May 30;128(22):1225-8.

• Document Type: article